A Study of HFB301001 in Adult Patients With Advanced Solid Tumors
Conditions:   Soft Tissue Sarcoma;   Renal Cell Carcinoma;   Uterine Carcinosarcoma;   Hepatocellular Carcinoma;   Head and Neck Squamous Cell Carcinoma Intervention:   Drug: HFB301001 Sponsor:   HiFiBiO Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2022 Category: Research Source Type: clinical trials

Nivolumab for Recurrent/Metastatic Carcinosarcoma
Condition:   Recurrent/Metastatic Carcinosarcoma Intervention:   Drug: nivolumab Sponsor:   Yonsei University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 4, 2022 Category: Research Source Type: clinical trials